Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiujin Ye

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Clinics (Sao Paulo, Brazil)|November 18, 2020
Prognostic significance of a normal karyotype in adult patients with BCR-ABL1-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor eraTing Shi, Huanping Wang, Mixue Xie, et al.
American Journal of Cancer Research|September 9, 2020
Adult Ph-positive acute lymphoblastic leukemia-current concepts in cytogenetic abnormalities and outcomesTing Shi, Xianbo Huang, Lixia Zhu, et al.
Platelets|December 27, 2019
A megakaryocyte morphological classification-based predictive model for steroid sensitivity in primary immune thrombocytopeniaJingjing Zhu, Rongrong Chen, Shuqi Zhao, et al.
Oncology Letters|January 19, 2018
Novel homobarringtonie-containing therapy for the treatment of patients with primary acute myeloid leukemia that are resistant to conventional therapyJingsong He, Li Li, Jingjing Zhu, et al.
Oncotarget|December 22, 2016
The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR/ABL proteinsLiangshun You, Hui Liu, Jian Huang, et al.
Therapeutic Advances in Hematology|February 19, 2025
Significance of whole-blood EBV DNA status in T/NK-cell lymphoma-associated hemophagocytic lymphohistiocytosis: a single-center retrospective analysisMengqi Xiong, Li Li, Lulu Wang, et al.
Annals of Hematology|June 2, 2023
Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosisQiaolei Zhang, Lixia Zhu, De Zhou, et al.
Frontiers in Oncology|August 2, 2021
The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid LeukemiaYuanfei Shi, Jing Ye, Ying Yang, et al.
Cancer Management and Research|June 27, 2019
The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagyXianbo Huang, Ying Li, Lihong Shou, et al.
Oncology Letters|January 27, 2017
Profiling of microRNAs in AML cells following overexpression or silencing of the VEGF geneLi Li, Lixia Zhu, Yungui Wang, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Clinics (Sao Paulo, Brazil)|November 18, 2020
Prognostic significance of a normal karyotype in adult patients with BCR-ABL1-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor eraTing Shi, Huanping Wang, Mixue Xie, et al.
American Journal of Cancer Research|September 9, 2020
Adult Ph-positive acute lymphoblastic leukemia-current concepts in cytogenetic abnormalities and outcomesTing Shi, Xianbo Huang, Lixia Zhu, et al.
Platelets|December 27, 2019
A megakaryocyte morphological classification-based predictive model for steroid sensitivity in primary immune thrombocytopeniaJingjing Zhu, Rongrong Chen, Shuqi Zhao, et al.
Oncology Letters|January 19, 2018
Novel homobarringtonie-containing therapy for the treatment of patients with primary acute myeloid leukemia that are resistant to conventional therapyJingsong He, Li Li, Jingjing Zhu, et al.
Oncotarget|December 22, 2016
The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR/ABL proteinsLiangshun You, Hui Liu, Jian Huang, et al.
Therapeutic Advances in Hematology|February 19, 2025
Significance of whole-blood EBV DNA status in T/NK-cell lymphoma-associated hemophagocytic lymphohistiocytosis: a single-center retrospective analysisMengqi Xiong, Li Li, Lulu Wang, et al.
Annals of Hematology|June 2, 2023
Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosisQiaolei Zhang, Lixia Zhu, De Zhou, et al.
Frontiers in Oncology|August 2, 2021
The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid LeukemiaYuanfei Shi, Jing Ye, Ying Yang, et al.
Cancer Management and Research|June 27, 2019
The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagyXianbo Huang, Ying Li, Lihong Shou, et al.
Oncology Letters|January 27, 2017
Profiling of microRNAs in AML cells following overexpression or silencing of the VEGF geneLi Li, Lixia Zhu, Yungui Wang, et al.
Pageof 9